Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 May-Jun;53(3):236-243.
doi: 10.4103/ijp.ijp_382_21.

Efficacy and safety of inhaled nitric oxide in the treatment of severe/critical COVID-19 patients: A systematic review

Ajay Prakash  1 , Sukhmeet Kaur  1 , Charanjeet Kaur  1 , Praisy K Prabha  1 , Anusuya Bhatacharya  2 , Phulen Sarma  1 , Bikash Medhi  1
Affiliations

Efficacy and safety of inhaled nitric oxide in the treatment of severe/critical COVID-19 patients: A systematic review

Ajay Prakash et al. Indian J Pharmacol. 2021 May-Jun.

Abstract

Objective: Present systematic review aimed to analyze the effect of inhaled nitric oxide (iNO) in the treatment of severe COVID-19 and to compare it to standard of care (SOC), antiviral medications, and other medicines.

Materials and methods: Medline (PubMed), Scopus, Embase, Ovid, Web of Science, Science Direct, Wiley Online Library, BioRxiv and MedRxiv, and Cochrane (up to April 20, 2021) were the search databases. Two reviewers (SK and CK) independently selected the electronic published literature that studied the effect of nitric oxide with SOC or control. The clinical and physiological outcomes such as prevention of progressive systemic de-oxygenation/clinical improvement, mortality, duration of mechanical ventilation, improvement in pulmonary arterial pressure, and adverse events were assessed.

Results: The 14 retrospective/protective studies randomly assigning 423 patients met the inclusion criteria. Cumulative study of the selected articles showed that iNO has a mild impact on ventilation time or ventilator-free days. iNO has increased the partial pressure of oxygen/fraction of inspired oxygen ratio of fraction of inspired oxygen in a few patients as compared to baseline. However, in most of the studies, it does not have better outcome when compared to the baseline improvement.

Conclusions: In patients with COVID-19 with acute respiratory distress syndrome, nitric oxide is linked to a slight increase in oxygenation but has no effect on mortality.

Keywords: COVID-19; Coronavirus; inhaled nitric oxide; nitric oxide; oxygenation; ventilation.

PubMed Disclaimer

Conflict of interest statement

None

Figures

Figure 1
Figure 1
PRISMA flowchart as per CONSORT statement
See this image and copyright information in PMC

References

    1. COVID-19 Coronavirus Pandemic. [Last accessed on 2021 May 11]. Available from: https://www.worldometers.info/coronavirus/?utm_campaign=homeAdvegas1?%22... .
    1. Ignarro LJ. Inhaled NO and COVID-19. Br J Pharmacol. 2020;177:3848–9. - PMC - PubMed
    1. Raju R, Prajith V, Biatris PS, Sam Johnson UC. Therapeutic role of corticosteroids in COVID-19: A systematic review of registered clinical trials. Futur J Pharm Sci. 2021;7:67. - PMC - PubMed
    1. Adusumilli NC, Zhang D, Friedman JM, Friedman AJ. Harnessing nitric oxide for preventing, limiting and treating the severe pulmonary consequences of COVID-19. Nitric Oxide. 2020;103:4–8. - PMC - PubMed
    1. Ferrari M, Santini A, Protti A, Andreis DT, Iapichino G, Castellani G, et al. Inhaled nitric oxide in mechanically ventilated patients with COVID-19. J Crit Care. 2020;60:159–60. - PMC - PubMed

Publication types